Addex Therapeutics (FRA:APE1) Short Interest


FRA:APE1 Addex Therapeutics Ltd FRA:APE1
7 GF Score
Price €4.90
GF Value €1.12
! 6 Warning Signs
View Full Analysis

What is Addex Therapeutics Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:APE1 vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Addex Therapeutics's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Addex Therapeutics Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Addex Therapeutics's Short Interest distribution charts can be found below:

* The bar in red indicates where Addex Therapeutics's Short Interest falls into.


FRA:APE1
7GF Score
Addex Therapeutics Ltd FRA:APE1
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Addex Therapeutics (FRA:APE1) Overvalued in 2026?

Based on GuruFocus' analysis, Addex Therapeutics stock appears to be overvalued. The current stock price of €4.90 is trading 337.5% above its estimated GF Value™ of €1.12.

Key valuation signals for FRA:APE1:

  • Short Interest:
  • GF Value™: €1.12 vs. price of €4.90 (337.5% above fair value)
  • GF Score™: 7/100 with 6 warning signs

No single metric tells the full story. See the FRA:APE1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Addex Therapeutics Business Description

Address Chemin des Mines 9, Geneva, CHE, 1202
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
7GF Score

Get the complete analysis for FRA:APE1

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.90
Price
€1.12
GF Value